{
    "root": "7bf6db4d-e390-4934-bca7-7a72e10d0015",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "REMERON",
    "value": "20250224",
    "ingredients": [
        {
            "name": "MIRTAZAPINE",
            "code": "A051Q2099Q",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_6950"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28017"
        },
        {
            "name": "HYDROXYPROPYL CELLULOSE (1600000 WAMW)",
            "code": "RFW2ET671P",
            "drugbank_id": "https://go.drugbank.com/drugs/DB00840"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30563"
        },
        {
            "name": "LACTOSE, UNSPECIFIED FORM",
            "code": "J2B2A4N98G",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_17716"
        },
        {
            "name": "HYPROMELLOSE, UNSPECIFIED",
            "code": "3NXW29V3WO",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11075"
        },
        {
            "name": "POLYETHYLENE GLYCOL 8000",
            "code": "Q662QK8M3B",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32234"
        },
        {
            "name": "FERRIC OXIDE YELLOW",
            "code": "EX438O2MRT",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50819"
        },
        {
            "name": "FERRIC OXIDE RED",
            "code": "1K09F3G675",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50819"
        },
        {
            "name": "ASPARTAME",
            "code": "Z0H242BBR1",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_2877"
        },
        {
            "name": "CITRIC ACID MONOHYDRATE",
            "code": "2968PHW8QP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_31404"
        },
        {
            "name": "CROSPOVIDONE (15 MPA.S AT 5%)",
            "code": "68401960MK"
        },
        {
            "name": "MANNITOL",
            "code": "3OWL53L36A",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_29864"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14158"
        },
        {
            "name": "POVIDONE, UNSPECIFIED",
            "code": "FZ989GH94E"
        },
        {
            "name": "SODIUM BICARBONATE",
            "code": "8MDF5V39QO",
            "drugbank_id": "https://go.drugbank.com/drugs/DB01390"
        },
        {
            "name": "SUCROSE",
            "code": "C151H8M554",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_17992"
        }
    ],
    "indications": {
        "text": "remeron/remeronsoltab indicated treatment major depressive disorder ( mdd ) adults [ ( 14 ) ] .",
        "doid_entities": [
            {
                "text": "major depressive disorder (DOID:1470)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_1470"
            },
            {
                "text": "depressive disorder (DOID:1596)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_1596"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "starting dose : 15-mg daily ; may increase maximum recommended dose 45 mg daily . ( 2.1 ) administer orally daily , preferably evening prior sleep . ( 2.1 ) administer remeronsoltab immediately removal blister pack . ( 2.2 ) reduce dose gradually discontinuing remeron/remeronsoltab . ( 2.6 , 5.14 )",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "remeron tablets supplied : tablet strength tablet color/shape tablet markings package configuration ndc code 15 mg yellow , oval tablet scored `` msd `` debossed one side `` 3 z `` side , sides score line bottle / 30 count 78206-160-01 30 mg red-brown , oval tablet scored `` msd `` debossed one side `` 5 z `` side , sides score line bottle / 30 count 78206-161-01",
    "adverseReactions": "remeron/remeronsoltab contraindicated patients : taking , within 14 days stopping , maois ( including maois linezolid intravenous methylene blue ) increased risk serotonin syndrome [ ( 5.3 ) , ( 7 ) ] . known hypersensitivity mirtazapine excipients remeron/remeronsoltab . severe skin , including reaction eosinophilia systemic symptoms ( dress ) , stevens-johnson syndrome , bullous dermatitis , erythema multiforme toxic epidermal necrolysis reported following remeron/remeronsoltab [ ( 5.6 ) , ( 6.2 ) ] .",
    "indications_original": "REMERON/REMERONSolTab are indicated for the treatment of major depressive disorder (MDD) in adults [see Clinical Studies (14)].",
    "contraindications_original": "Starting dose: 15-mg once daily; may increase up to maximum recommended dose of 45 mg once daily. ( 2.1 ) Administer orally once daily, preferably in the evening prior to sleep. ( 2.1 ) Administer REMERONSolTab immediately after removal from blister pack. ( 2.2 ) Reduce dose gradually when discontinuing REMERON/REMERONSolTab. ( 2.6 , 5.14 )",
    "warningsAndPrecautions_original": "REMERON tablets are supplied as:\n                  \n                     \n                     \n                     \n                     \n                     \n                     \n                        \n                           Tablet Strength\n                           Tablet Color/Shape\n                           Tablet Markings\n                           Package Configuration\n                           NDC Code\n                        \n                     \n                     \n                        \n                           15 mg\n                           Yellow, oval tablet\n                           Scored with \"MSD\" debossed on one side and \"T\n                              3\n                              Z\" on other side, on both sides of score line\n                           Bottle / 30 count\n                           78206-160-01\n                        \n                        \n                           30 mg\n                           Red-brown, oval tablet\n                           Scored with \"MSD\" debossed on one side and \"T\n                              5\n                              Z\" on other side, on both sides of score line\n                           Bottle / 30 count\n                           78206-161-01",
    "adverseReactions_original": "REMERON/REMERONSolTab is contraindicated in patients:\n                  \n                     Taking, or within 14 days of stopping, MAOIs (including the MAOIs linezolid and intravenous methylene blue) because of an increased risk of serotonin syndrome [see Warnings and Precautions (5.3), Drug Interactions (7)].\n                     \n                        With a known hypersensitivity to mirtazapine or to any of the excipients in REMERON/REMERONSolTab. Severe skin reactions, including drug reaction with eosinophilia and systemic symptoms (DRESS), Stevens-Johnson syndrome, bullous dermatitis, erythema multiforme and toxic epidermal necrolysis have been reported following the use of REMERON/REMERONSolTab [see Warnings and Precautions (5.6), Adverse Reactions (6.2)].",
    "drug": [
        {
            "name": "REMERON",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_6950"
        }
    ]
}